UNI-EN 1:„Sopharma” AD now owns 100% of the capital of the subsidiary BRIZ, Latvia
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 1 | / | 2021 | |||||||
| Date of issue: | 2021-01-08 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| „Sopharma” AD now owns 100% of the capital of the subsidiary BRIZ, Latvia | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sofia, Bulgaria, January 8, 2021 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on December 28, 2020 as a result of long and successful negotiations with the remaining shareholders of BRIZ a change in the shareholders’ structure was finalized with the Commercial Register of the Republic of Latvia, which makes “Sopharma” AD the only shareholder owning 100% of the shares in the company. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_Sopharma_Briz_EN_espi.pdf 3JR_Sopharma_Briz_EN_espi.pdf | „Sopharma” AD now owns 100% of the capital of the subsidiary BRIZ, Latvia | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2021-01-08 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 10.7 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
